Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.

Brent J SmallMarie LangeWanting ZhaiJaeil AhnTim A AhlesJudith E CarrollHarvey J CohenDeena GrahamMartine ExtermannNatacha HeutteHeather S L JimBrenna C McDonaldSunita K PatelJames C RootAndrew J SaykinKathleen Van DykXingtao ZhouJeanne MandelblattFlorence Jolynull null

Published in: Breast cancer research and treatment (2021)

Older women who received treatment with taxanes did not have greater declines in cognitive performance or well-being than women receiving other chemotherapy regimens. Despite older cancer survivors being at greater risk for negative outcomes, treatment with taxane-based chemotherapies does not appear to exacerbate these health consequences.

Keyphrases

healthcare
public health
mental health
physical activity
young adults
type diabetes
multiple sclerosis
white matter
combination therapy
polycystic ovary syndrome
locally advanced
metabolic syndrome
pregnant women
insulin resistance
health information
climate change
chemotherapy induced